Mejia, Miecel C.

HRN: 23-78-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFUROXIME 1.5GM (VIAL)
09/29/2023
09/30/2023
IV
1.5g
Q8
S/P NSVD To Stillborn; CAP
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  PneumoniaReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: